MiR-93 Promotes Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer Cells by Activating the PI3K/Akt Pathway via Inhibition of LKB1/PTEN/CDKN1A

Background: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of clinical lung cancer cases. MicroRNA-93 (miR-93) is an oncomiR in many types of human cancer, exerting pivotal effects in the development and progression of malignancies, including NSCLC. However, the mechanism underlyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunmei, Lyu, Jianxin, Meng, Qing H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381176/
https://www.ncbi.nlm.nih.gov/pubmed/28382150
http://dx.doi.org/10.7150/jca.17958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381176/
https://www.ncbi.nlm.nih.gov/pubmed/28382150
http://dx.doi.org/10.7150/jca.17958

Ejemplares similares